235 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
6
Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
King Saud University
15
Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome.
Temple University
16
A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptorsa andß.
Purdue University
7
Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Central University of Punjab
21
Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.
State University of New York Upstate Medical University
28
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors.
University of Chieti 'G. D'Annunzio
4
Exploring new chemical functionalities to improve aromatase inhibition of steroids.
University of Coimbra
3
Isocoumarins, miraculous natural products blessed with diverse pharmacological activities.
Quaid-I-Azam University
21
Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis.
University of Bologna
147
Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
The M. S. University of Baroda
45
Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
American University of Ras Al Khaimah
22
Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.
Merck Research Laboratories
70
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
University of Bath
24
Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
Srinakharinwirot University
37
Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.
Merck Research Laboratories
30
Identification of 4-(4-nitro-2-phenethoxyphenyl)pyridine as a promising new lead for discovering inhibitors of both human and rat 11ß-Hydroxylase.
Saarland University
25
Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
Purdue University
28
Novel pyridyl substituted 4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines as potent and selective aldosterone synthase inhibitors with improved in vitro metabolic stability.
Saarland University and Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
5
Exemestane metabolites: Synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line.
University of Coimbra
16
Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthase.
Saarland University
5
Bioactive benzofuran derivatives: moracins A-Z in medicinal chemistry.
Dongguk University-Seoul
2
Spongiapyridine and related spongians isolated from an Indonesian Spongia sp.
University of Hawaii At Manoa
21
Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases.
Saarland University and Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
29
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11ß-hydroxylase.
University of Bari Aldo Moro
8
Discovery of a new class of cinnamyl-triazole as potent and selective inhibitors of aromatase (cytochrome P450 19A1).
Mcmaster University
2
Inhibitory effect of Rhus verniciflua Stokes extract on human aromatase activity; butin is its major bioactive component.
Hanyang University
14
Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.
Northern Kentucky University
25
Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors.
Novartis Institutes For Biomedical Research
17
Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
Mcmaster University
22
Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors.
University of Padova
4
Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles.
University of Bologna
20
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.
Saarland University & Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
6
Synthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities.
Purdue University
20
Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives.
Key Laboratory of Medicinal Chemistry For Natural Resource (Yunnan University)
18
Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11ß-hydroxylase inhibition.
University of Bologna
30
Tetrahydropyrroloquinolinone type dual inhibitors of aromatase/aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks.
Saarland University & Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
5
Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activity.
Institute of Cancer Research
7
Synthesis and evaluation of 4-(substituted thio)-4-androstene-3,17-dione derivatives as potential aromatase inhibitors.
TBA
8
Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).
Purdue University
11
Novel aromatase inhibitors by structure-guided design.
State University of New York Upstate Medical University
17
Selective dual inhibitors of CYP19 and CYP11B2: targeting cardiovascular diseases hiding in the shadow of breast cancer.
Saarland University & Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
19
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome.
Saarland University and Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
8
New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.
University of Coimbra
25
Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
Northern Kentucky University
7
Radical scavenging and antioxidant activities of isocoumarins and a phthalide from the endophytic fungus Colletotrichum sp.
Chulabhorn Institute
20
Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitors.
Saarland University
26
Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Purdue University
15
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation.
University of Bologna
53
Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
Johns Hopkins University
43
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.
University of Bath
8
Screening of herbal constituents for aromatase inhibitory activity.
King'S College London
3
Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.
Universidade Federal De Minas Gerais
42
"Virtual fragment linking": an approach to identify potent binders from low affinity fragment hits.
Novartis Institutes For Biomedical Research
13
New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
Upres Ea 4021 Biomol�Cules Et Th�Rapies Anti-Tumorales
65
Novel sulfonanilide analogs decrease aromatase activity in breast cancer cells: synthesis, biological evaluation, and ligand-based pharmacophore identification.
The Ohio State University
24
Synthesis and biological evaluation of (+/-)-abyssinone II and its analogues as aromatase inhibitors for chemoprevention of breast cancer.
Purdue University
5
Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation.
University of Oporto
3
Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition.
Bristol Myers Squibb
13
Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
Centre De Recherches Roussel-Uclaf
14
Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
Tohoku College of Pharmacy
13
Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease.
Ciba-Geigy
34
Mechanism and inhibition of cytochrome P-450 aromatase.
Johns Hopkins University School of Medicine
68
Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups.
Eli Lilly
13
Effects of steroid D-ring modification on suicide inactivation and competitive inhibition of aromatase by analogues of androsta-1,4-diene-3,17-dione.
Washington University
6
Interactions of thiol-containing androgens with human placental aromatase.
University of Washington
1
Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage.
TBA
21
Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.
Purdue University
10
New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.
Novartis Institutes For Biomedical Research
42
Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.
Purdue University
8
Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
Mcmaster University
26
Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agents.
University of Hawaii At Hilo
36
Recent progress in synthesis and bioactivity studies of indolizines.
University of Botswana
68
Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors.
Universite de Moncton
31
Structure-based design of potent aromatase inhibitors by high-throughput docking.
Universita` Di Modena E Reggio Emilia
9
Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Upres Ea 4021 Biomol�Cules Et Th�Rapies Anti-Tumorales
36
Fine-tuning the selectivity of aldosterone synthase inhibitors: structure-activity and structure-selectivity insights from studies of heteroaryl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivatives.
Saarland University
36
Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-a-hydroxylase/C17-20 lyase.
Universita` Degli Studi Di Bari Aldo Moro
14
Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity
TBA
10
N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2).
Saarland University & Helmholtz Institute For Pharmaceutical Research Saarland
32
Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
Tianjin University of Science and Technology
52
Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies.
University of Calcutta
30
Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer.
Saarland University
1
Aspergillusol A, an alpha-glucosidase inhibitor from the marine-derived fungus Aspergillus aculeatus.
Institute and The Center For Environmental Health
8
An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
Universidade De Coimbra
3
Monodictyochromes A and B, Dimeric Xanthone Derivatives from the Marine Algicolous Fungus Monodictys putredinis.
University of Bonn
16
Synthesis and biochemical evaluation of a range of sulfonated derivatives of 4-hydroxybenzyl imidazole as highly potent inhibitors of rat testicular 17alpha-hydroxylase/17,20-lyase (P-450(17alpha)).
University of The West of Scotland
88
Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.
Universidade De Coimbra
33
In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives.
Saarland University
39
CYP19 (aromatase): exploring the scaffold flexibility for novel selective inhibitors.
Università
29
Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach.
Saarland University
35
Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity.
Saarland University
9
Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.
Université
4
Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity.
University of Illinois At Chicago
9
Evaluation of ursolic acid isolated from Ilex paraguariensis and derivatives on aromatase inhibition.
Universidade Federal Do Rio Grande Do Sul (Ufrgs)
7
Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay.
University of Illinois At Chicago
20
Research progress of flavonoids targeting estrogen receptor in the treatment of breast cancer.
University of South China
4
Discovery of novel benzoxazole analogues as potential anticancer agent selectively targeting aromatase.
Commerce and Science College
11
Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy.
The First Affiliated Hospital of Henan University
7
Novel mitochondrial and DNA damaging fluorescent Calix[4]arenes bearing isatin groups as aromatase inhibitors: Design, synthesis and anticancer activity.
University of Selcuk
31
Targeting aromatase to restrain oestrogen production and developing efficacious interventions against ER-positive cancer.
Guru Nanak Dev University
20
Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer.
Zhongnan Hospital of Wuhan University
23
Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application.
China Pharmaceutical University
7
Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells.
The Ohio State University
6
Potential cancer chemopreventive in vitro activities of monomeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis.
University of Bonn
51
Structure-guided identification of novel dual-targeting estrogen receptor α degraders with aromatase inhibitory activity for the treatment of endocrine-resistant breast cancer.
Zhongnan Hospital of Wuhan University
15
Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy.
University of Bologna
22
Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation.
Hunan University of Science and Technology
2
Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
Jadavpur University
4
Resveratrol - A comprehensive review of recent advances in anticancer drug design and development.
Mazandaran University of Medical Sciences
22
Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.
Northwest University
27
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist.
Shandong University
10
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme.
University of Bologna
8
Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors.
Anadolu University
18
Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition.
The Ohio State University
7
Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors.
Nantes University
39
Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[
Guangzhou University of Chinese Medicine
31
4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors.
Cardiff University
6
Inhibition of cytochrome P450 monooxygenase-catalyzed oxylipin formation by flavonoids: Evaluation of structure-activity relationship towards CYP4F2-selective inhibitors.
University of Wuppertal
21
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Zhejiang University
14
Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
Central University of Punjab
5
Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Upres Ea 1085 BiomoléCules Et Cibles Cellulaires Tumorales
14
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer.
University of Bologna
9
Diterpenoids with Aromatase Inhibitory Activity from the Rhizomes of
Chulabhorn Royal Academy
7
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors.
"G. d'Annunzio" University of Chieti-Pescara
2
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors.
"G. d'Annunzio" University of Chieti-Pescara
9
Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile.
Bristol Myers Squibb
12
Preparation and pharmacological profile of 7-(alpha-azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors.
Ufr Des Sciences Pharmaceutiques
18
Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.
Purdue University
5
Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition.
Upres Ea 1085
7
New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives.
Upres Ea 1085
16
A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
University of Bologna
4
Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors.
University of Bologna
23
Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17).
University of The Saarland
14
Synthesis and aromatase inhibitory evaluation of 4-N-nitrophenyl substituted amino-4H-1,2,4-triazole derivatives.
Key Laboratory of Industrial Fermentation Microbiology (Tianjin University of Science & Technology)
11
Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1.
University of Washington
27
Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
University of Sharjah
59
Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
Indian Institute of Technology (Bhu)
8
1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.
Cardiff University
14
C-6α- vs C-7α-Substituted Steroidal Aromatase Inhibitors: Which Is Better? Synthesis, Biochemical Evaluation, Docking Studies, and Structure-Activity Relationships.
University of Coimbra
7
Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.
Cnr-Iom-Democritos C/O International School For Advanced Studies (Sissa)
9
New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2,3 or 5-(alpha-azolylbenzyl)-1H-indoles.
Nantes
21
Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors.
Srinakharinwirot University
4
Design and synthesis of a new type of non steroidal human aromatase inhibitors.
Centre D'Etudes Et De Recherche Sur Le MéDicament De Normandie
17
Indole: A privileged scaffold for the design of anti-cancer agents.
Hunan University of Science and Technology
13
Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors.
Mcmaster University
5
6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
University of Minnesota
3
6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist.
Smithkline Beecham Pharmaceuticals
5
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
"G. d'Annunzio" University of Chieti-Pescara
13
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer.
Cancer Research Campaign Centre For Cancer Therapeutics
1
Development of Highly Selective Pyrimidine-Based Aldosterone Synthase (CYP11B2) Inhibitors.
Selenity Therapeutics
23
Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17.
UniversitäT De Saarlandes
11
Discovery of N-[5-(6-Chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-ethanesulfonamide, a Cortisol-Sparing CYP11B2 Inhibitor that Lowers Aldosterone in Human Subjects.
Novartis Institutes For Biomedical Research
8
Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds.
Ciba-Geigy
5
Selective inhibition of mammalian lanosterol 14 alpha-demethylase: a possible strategy for cholesterol lowering.
Syntex Discovery Research
16
6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
Tohoku College of Pharmacy
25
Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins.
UniversitäT Des Saarlandes
22
Synthesis of androst-5-en-7-ones and androsta-3,5-dien-7-ones and their related 7-deoxy analogs as conformational and catalytic probes for the active site of aromatase.
Tohoku College of Pharmacy
13
Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom.
UniversitäT Des Saarlandes
8
Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
Ohio State University
15
Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer.
Institute of Cancer Research
4
Probing the hydrophobic pocket of the active site of aromatase with 4-phenoxy-7 alpha-(phenylthio)-4-androstene-3,17-dione.
University of Minnesota
18
Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysis.
Crc Laboratory
6
Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione.
TBA
14
Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones.
TBA
20
Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents.
TBA
27
Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives.
Istanbul Medipol University
11
Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity.
Boehringer Ingelheim Pharmaceuticals
10
Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.
University of Hawai'I At Hilo
21
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
University of Basel
21
Potent aromatase inhibitors and molecular mechanism of inhibitory action.
Yunnan University
36
Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors.
Srinakharinwirot University
22
Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives.
Institute of Cancer Research
7
Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
Ohio State University
18
Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid.
Institute of Cancer Research
34
Design and synthesis of functionalized piperazin-1yl-(E)-stilbenes as inhibitors of 17α-hydroxylase-C17,20-lyase (Cyp17).
Temple University
22
Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors.
Viamet Pharmaceuticals
7
Novel time-dependent inhibitors of human placental aromatase.
Marion Merrell Dow Research Institute
8
Inhibition of human placental aromatase by novel homologated 19-oxiranyl and 19-thiiranyl steroids.
Johns Hopkins University School of Medicine
15
Synthesis and aromatase inhibitory activity of novel 1-(4-aminophenyl)-3-azabicyclo[3.1.0]hexane- and -[3.1.1]heptane-2,4- diones.
Ciba-Geigy
15
New aromatase inhibitors. Synthesis and biological activity of pyridyl-substituted tetralone derivatives.
UniversitäT Des Saarlandes
5
Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
King Saud University
5
Synthesis and aromatase inhibition of 3-cycloalkyl-substituted 3-(4-aminophenyl)piperidine-2,6-diones.
UniversitäT Des Saarlandes
31
Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension.
Merck Research Laboratories
19
Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
Health Sciences University of Hokkaido
10
Conformational analysis of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione (rogletimide) and discovery of potent 5-alkyl derivatives.
Institute of Cancer Research
27
Methods and composition of 4-substituted benzoylpiperazine-1-substituted carbonyls as beta-catenin/B-cell lymphoma 9 inhibitors
Universisity of Utah Research Foundation
14
Oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection
Hoffmann-La Roche
27
Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors
Iteos Therapeutics
295
Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
Merck Patent
113
Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Bristol Myers Squibb
21
2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease
H. Lundbeck
18
2-amino-5,5-difluoro-6-(fluoromethyl)-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors
H. Lundbeck
137
Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
Novartis
2236
Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same
Shionogi
5
Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases
Zhejiang Dtrm Biopharma
1
Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency.
AstraZeneca
16
Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists.
Astellas Pharma
16
Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication.
Schering-Plough Research Institute
22
Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues.
Medivir
22
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.
Roche Products
24
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.
Laboratoires Glaxo
50
5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
Sapienza University of Rome
12
2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones.
Universita Di Roma
59
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.
Eli Lilly